Neue Suche | Kongressdetail
mail
Druckansicht
 
 

2nd ADC Toxicity Summit

Evvnt Promotion / evvnt
-
23.07.2024 - 25.07.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Kongressthemen
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing companies entering into the ADC space and tackling toxicity, there is ever-increasing target and indication-competition. Considering the significant clinical setbacks witnessed in 2023, the demand to better understand the translatability of toxicities and develop more tolerable ADCs for achieving future clinical triumphs only grows stronger.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade Group
Anmerkungen
Brochure: https://go.evvnt.com/2381308-3?pid=4832

Speakers: Ali Warbington, Director, Toxicology, ImmunoGen, Arnima Bisht, Senior Director, Oxford BioTherapeutics and More.
 

Anfragen und Anmeldung:

https://go.evvnt.com/2381308-2?pid=4832
Herr Luke Kelly
 
Kategorien
Immunologie und Pathologie, Pharmakologie und Toxikologie
Sprache
Englisch
Kongressgebühr
FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4197.00, Conference Only - Drug Developer: USD 2999.00, FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5097.00, Conference Only - Solution Provider: USD 3699.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Swiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)Anästhesie in Entwicklungsländern e. V.Ärztekammer für WienCenter of ExcellenceÄrzte der Welt